1.Valsalva retinopathy during end stage labour:considerations for treatment (a case report)
Konstantinos I PAPAGEORGIOU ; Rashmi G MATHEW ; Alexanoer S IOANNIDIS ; Ajay, SINHA ; Petros S ANDREOU
International Eye Science 2007;7(3):621-622
AIM: To discuss the options for treatment (conservative versus surgical) in cases of Valsalva Retinopathy, reported during pregnancy.METHODS:We report the case of a healthy pregnant woman, who developed a dense premacular subhyaloid haemorrhage, in the right eye following a normal spontaneous vaginal delivery. She was managed conservatively.RESULTS: At 3 weeks the haemorrhage had contracted and the vision was HM but by the 6th month, the haemorrhage had resolved and vision returned to 6/5 in the right eye.CONCLUSION: Most cases of Valsalva retinopathy resolve spontaneously. Authors have shown the beneficial effect of Nd:YAG membranotomy of the internal limiting membrane.Early vitrectorny has also been advocated, as it delaminates the membrane which can act a scaffold for neovascularization.
2.Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
Ajit SOOD ; Vineet AHUJA ; Vandana MIDHA ; Saroj Kant SINHA ; C. Ganesh PAI ; Saurabh KEDIA ; Varun MEHTA ; Sawan BOPANNA ; Philip ABRAHAM ; Rupa BANERJEE ; Shobna BHATIA ; Karmabir CHAKRAVARTTY ; Sunil DADHICH ; Devendra DESAI ; Manisha DWIVEDI ; Bhabhadev GOSWAMI ; Kirandeep KAUR ; Rajeev KHOSLA ; Ajay KUMAR ; Ramit MAHAJAN ; S. P. MISRA ; Kiran PEDDI ; Shivaram Prasad SINGH ; Arshdeep SINGH
Intestinal Research 2020;18(4):355-378
Despite several recent advances in therapy in inflammatory bowel disease (IBD), 5-aminosalicylic acid (5-ASA) therapy has retained its place especially in ulcerative colitis. This consensus on 5-ASA is obtained through a modified Delphi process, and includes guiding statements and recommendations based on literature evidence (randomized trials, and observational studies), clinical practice, and expert opinion on use of 5-ASA in IBD by Indian gastroenterologists. The aim is to aid practitioners in selecting appropriate treatment strategies and facilitate optimal use of 5-ASA in patients with IBD.